TRANS GENIC GROUP INC. Logo

TRANS GENIC GROUP INC.

Biotech firm offering drug discovery support and investment/consulting services.

2342 | T

Overview

Corporate Details

ISIN(s):
JP3635720000
LEI:
Country:
Japan
Address:
福岡市中央区天神二丁目3番36号

Description

TRANS GENIC GROUP INC. is a biotechnology company that operates through two main business segments: Drug Discovery Support and Investment & Consulting. The Drug Discovery Support division provides comprehensive services across the entire drug development pipeline, from basic research to non-clinical and clinical trials. Core services include the contract production of genetically modified animals, particularly mice, using genome editing technologies like CRISPR/Cas9. The company also specializes in contract antibody production, glycosylation analysis, and the supply of model mice. The Investment & Consulting segment focuses on M&A, business succession, and providing advisory and support services for business revitalization.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-02-13 06:23
四半期報告書-第25期第3四半期(2022/10/01-2022/12/31)
Japanese 170.6 KB
2022-11-14 01:59
確認書
Japanese 8.1 KB
2022-11-14 01:57
四半期報告書-第25期第2四半期(令和4年7月1日-令和4年9月30日)
Japanese 196.6 KB
2022-08-12 08:46
確認書
Japanese 8.1 KB
2022-08-12 08:45
四半期報告書-第25期第1四半期(令和4年4月1日-令和4年6月30日)
Japanese 158.7 KB
2022-06-24 07:37
確認書
Japanese 8.2 KB
2022-06-24 07:36
内部統制報告書-第24期(令和3年4月1日-令和4年3月31日)
Japanese 22.4 KB
2022-06-24 07:35
有価証券報告書-第24期(令和3年4月1日-令和4年3月31日)
Japanese 1.1 MB
2022-02-14 07:53
四半期報告書-第24期第3四半期(令和3年10月1日-令和3年12月31日)
Japanese 198.3 KB
2021-11-15 03:53
四半期報告書-第24期第2四半期(令和3年7月1日-令和3年9月30日)
Japanese 211.9 KB
2021-08-13 08:46
四半期報告書-第24期第1四半期(令和3年4月1日-令和3年6月30日)
Japanese 176.5 KB
2021-06-24 04:07
確認書
Japanese 8.1 KB
2021-06-24 04:05
内部統制報告書-第23期(令和2年4月1日-令和3年3月31日)
Japanese 22.4 KB
2021-06-24 04:04
有価証券報告書-第23期(令和2年4月1日-令和3年3月31日)
Japanese 1.0 MB
2021-02-15 02:13
四半期報告書-第23期第3四半期(令和2年10月1日-令和2年12月31日)
Japanese 174.4 KB

Automate Your Workflow. Get a real-time feed of all TRANS GENIC GROUP INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TRANS GENIC GROUP INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TRANS GENIC GROUP INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.